Maternal Age at Birth and Gastroschisis Prevalence in the United States and Puerto Rico, 2000-2020

Julie M Petersen1,2,3, Jeremy M Schraw4, Mahsa M Yazdy2

  • 1Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Insights

Gastroschisis prevalence in the US increased, peaked, then declined. This pattern reflects fewer births to younger mothers, not increased risk in that group.

Area of Science:

  • Pediatric Surgery
  • Congenital Anomalies
  • Epidemiology

Background:

  • Gastroschisis is a serious congenital anomaly requiring surgical repair.
  • Young maternal age is the strongest identified risk factor for gastroschisis.

Purpose of the Study:

  • To describe gastroschisis prevalence in the US and Puerto Rico from 2000-2020.
  • To examine if maternal age trends explain observed gastroschisis prevalence patterns.

Main Methods:

  • Utilized data from 46 state and territorial surveillance systems.
  • Calculated gastroschisis prevalence using 5-year averages and 2-year moving averages.
  • Computed expected prevalence based on maternal age-specific estimates and US live births.

Main Results:

  • Gastroschisis prevalence increased from 2000-2004, peaked in 2008-2012 (5.44/10,000 births), and declined by 2016-2020 (4.47/10,000 births).
  • Expected prevalence patterns closely mirrored observed patterns.
  • Prevalence changes correlate with a decrease in US births among women under 25.

Conclusions:

  • Gastroschisis prevalence trends are primarily influenced by shifts in maternal age demographics.
  • The decline in prevalence is linked to fewer births among younger women, not a reduced risk within that age group.

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
828
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
58.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K